Abstract. Microinjection of human Jurkat T-lymphocytes with nicotinic acid adenine dinucleotide phosphate (NAADP ϩ ) dose-dependently stimulated intracellular Ca 2 ϩ -signaling. At a concentration of 10 nM NAADP ϩ evoked repetitive and long-lasting Ca 2 ϩ -oscillations of low amplitude, whereas at 50 and 100 nM, a rapid and high initial Ca 2 ϩ -peak followed by trains of smaller Ca 2 ϩ -oscillations was observed. Higher concentrations of NAADP ϩ (1 and 10 M) gradually reduced the initial Ca 2 ϩ -peak, and a complete self-inactivation of Ca 2 ϩ -signals was seen at 100 M. The effect of NAADP ϩ was specific as it was not observed with nicotinamide adenine dinucleotide phosphate. Both inositol 1,4,5-trisphosphate-and cyclic adenosine diphosphoribose-mediated Ca 2 ϩ -signaling were efficiently inhibited by coinjection of a self-inactivating concentration of NAADP ϩ . Most importantly, microinjection of a self-inactivating concentration of NAADP ϩ completely abolished subsequent stimulation of Ca 2 ϩ -signaling via the T cell receptor/CD3 complex, indicating that a functional NAADP ϩ Ca 2 ϩ -release system is essential for T-lymphocyte Ca 2 ϩ -signaling.
Introduction
Activation of T-lymphocytes via the T cell receptor/CD3 (TCR/CD3) 1 complex results in multiple intracellular signaling pathways (Kennedy et al., 1999) . Among these pathways, an elevation of [Ca 2 ϩ ] i (intracellular Ca 2 ϩ -concentration) is essential for proliferation and clonal expansion (reviewed in Guse, 1998) . The increase of [Ca 2 ϩ ] i in T cells consists of calcium release from intracellular stores, and, as a major source for the long-lasting Ca 2 ϩ -signal observed in T cells, subsequent entry of calcium through specific calcium channels in the plasma membrane (reviewed in Guse, 1998) . Ca 2 ϩ -release is activated by the calcium mobilizing second messengers D -myo -inositol 1,4,5-trisphosphate(Ins(1,4,5)P 3 ) and cyclic ADP-ribose (cADPR).
Recent work indicates that Ins(1,4,5)P 3 primarily acts during the initial phase of Ca 2 ϩ -signaling in T cells, whereas cADPR is essentially involved in the sustained phase of Ca 2 ϩ -signaling (Guse et al., 1999) . Besides Ins(1,4,5)P 3 and cADPR, another Ca 2 ϩ -mobilizing natural compound, nicotinic acid adenine dinucleotide phosphate (NAADP ϩ ) was introduced (Chini et al., 1995; Lee and Aarhus, 1995) . NAADP ϩ was originally discovered as a contaminant of commercial nicotinamide adenine dinucleotide phosphate (NADP ϩ ) preparations; such preparations could also be enriched in NAADP ϩ content by alkaline treatment (Clapper et al., 1987) . Very low concentrations of NAADP ϩ in the range of 10-50 nM were shown to effectively release Ca 2 ϩ from intracellular stores of selected invertebrate and mammalian cell types, such as sea urchin eggs (Lee and Aarhus, 1995) , ascidian oocytes (Albrieux et al., 1998) , and mouse pancreatic acinar cells . NAADP ϩ -mediated Ca 2 ϩ -release was not sensitive to the cADPR antagonist, 8-NH 2 -cADPR; the Ins(1,4,5)P 3 antagonist, heparin (Lee and Aarhus, 1995) ; or to the antagonists of ryanodine receptors (RyR), procaine or ruthenium red (Chini et al., 1995) . Together, with the lack of cross-desensitization observed between the NAADP ϩ /Ca 2 ϩ -release system on one hand, and the 582 cADPR/-or the Ins(1,4,5)P 3 /Ca 2 ϩ -release systems on the other hand (Chini et al., 1995; Lee and Aarhus, 1995) , these data indicate that the NAADP ϩ -dependent Ca 2 ϩ -release system is different from the two others. Although the receptor for NAADP ϩ has not yet been identified, unspecific effects of NAADP ϩ are largely unlikely since concrete structural requirements for NAADP ϩ -mediated Ca 2 ϩ -release were demonstrated in sea urchin eggs, e.g., the NH 2 -group at position 6 of the adenine ring or the phosphate group at the 2 Ј -position of the ribose are necessary (Lee and Aarhus, 1997) . The latter can be replaced by a 3 Ј -phosphate or a 2 Ј ,3 Ј -cyclic phosphate, but this alteration resulted in a weaker Ca 2 ϩ -release activity (Lee and Aarhus, 1997) . Further characteristic properties of NAADP ϩ -mediated Ca 2 ϩ -release in sea urchin eggs are a unique self inactivation or self desensitization process (Aarhus et al., 1996; , and Ca 2 ϩ -release from a thapsigargin-insensitive Ca 2 ϩ -pool .
The fact that recent reports indicated a role for NAADP ϩ in Ca 2 ϩ -signaling of mammalian cells (Bak et al., 1999; Cancela et al., 1999) prompted us to study its effects in human Jurkat T cells. We report here that NAADP ϩ specifically and dose-dependently stimulated Ca 2 ϩ -signaling when microinjected into intact Jurkat T cells. Furthermore, we show that self inactivation of the NAADP ϩ /Ca 2 ϩ -release system almost completely inhibited Ins(1,4,5)P 3 -or cADPR-mediated Ca 2 ϩ -signaling. Most importantly, we demonstrate that self inactivation of the NAADP ϩ /Ca 2 ϩ -release also completely antagonized Ca 2 ϩ -signaling mediated by ligation of the TCR/CD3-complex.
Materials and Methods
Reagents cADPR, 8-OCH 3 -cADPR, and D -myo -inositol 1,4,6-trisphosphorothioate (Ins(1,4,6)PS 3 ) were synthesized exactly as described (Ashamu et al., 1995; Murphy et al., 2000) , purified by anion-exchange chromatography on Q-Sepharose, and used as their triethylammonium salts. Purity of ligands was assessed by 1 H and 31 P NMR spectroscopy, mass spectroscopy, and, when appropriate, HPLC. NAADP ϩ and NADP ϩ were purchased from Sigma-Aldrich. The purity of NAADP ϩ was described by the manufacturer to be ‫ف‬ 95%; this was confirmed by reverse phase HPLC using the method of da Silva et al. (1998) . Fura 2/AM was obtained from Calbiochem. Anti-CD3 mAb OKT3 was purified from hybridoma supernatant on protein G-Sepharose.
Cell Culture
Jurkat T lymphocytes (subclone JMP) were cultured in RPMI 1640 medium containing the following additions: glutamax I, Hepes (20 mM, pH 7.4), NCS (7.5%), penicillin (100 U/ml), and streptomycin (50 g/ml; all obtained from Life Technologies). The cells were cultured at 37 Њ C in a humidified atmosphere in the presence of 5% CO 2 .
Ratiometric Ca 2 ϩ Imaging
Batches of 10 7 Jurkat T cells were loaded with Fura2/AM as described (Guse et al., 1993) . Fura2-loaded cells (10 7 cells/5 ml) were kept at room temperature until use. Glass coverslips were coated first with BSA (5 mg/ml), and then with poly-L -lysine (0.1 mg/ml). Small chambers consisting of a rubber O-ring were sealed on the coverslips by silicon grease. Then, 90 l of extracellular buffer (140 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 1 mM CaCl 2 , 20 mM Hepes, 1 mM NaH 2 PO 4 , 5.5 mM glucose, pH 7.4) was added, followed by addition of 10 l cell suspension. The coverslip was mounted on the stage of an inverted microscope (Axiovert 100, ZEISS). Ratiometric Ca 2 ϩ imaging was performed using a PhotoMed/ Photon Technology (Wedel) digital imaging system built around the Axiovert 100 microscope. Illumination at 340 and 380 nm was carried out using a chopper/optical filter system. Images were captured by an intensified CCD camera (type C2400-77; spatial resolution: 525 ϫ 487 pixel; Hamamatsu) and stored as individual 340 and 380 images on hard disk. Sampling rate was usually 5 s for a pair of images (340 and 380 nm) using 100-fold magnification. Data analysis was performed off-line using PhotoMed/Photon Technology (Wedel) Image master analysis software. Ratio images (340/380) were constructed pixel by pixel, and changes in the ratio over time were measured by applying regions-of-interest on individual cells. Finally, ratio values were converted to Ca 2 ϩ -concentrations by external calibration.
Microinjection Experiments
Parallel Ca 2ϩ imaging and microinjection experiments require a firm attachment of the Jurkat T cells without preactivation of intracellular Ca 2ϩ -signaling. This was achieved by the above mentioned coating procedure of the glass coverslips, as detailed earlier (Guse et al., 1997) . The cells were kept in a small chamber (100 l vol) in extracellular buffer (140 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 1 mM CaCl 2 , 20 mM Hepes, 1 mM NaH 2 PO 4 , 5.5 mM glucose, pH 7.4). Compounds to be microinjected were cleared from particles by either filtration through 0.45-m filters, by centrifugation in an Eppendorf centrifuge at maximal speed for 10 min, or by both. Femtotips II (Eppendorf) were filled with 5 l of reagent solution and inserted into the semiautomatic microinjection system (Transjector 5246, Micromanipulator 5171, Eppendorf). Injection parameters were: injection pressure, 80 hPa; compensatory pressure, 40 hPa; duration of injection. 0.5 s; velocity of pipette, 700 m/s; pipette angle, 45Њ. Injections were performed into the upper part of the cell.
Results

Microinjection of NAADP
ϩ at a pipette concentration as low as 10 nM stimulated repetitive, long-lasting Ca 2ϩ -spiking of low amplitude in intact Jurkat T cells, whereas injection of intracellular buffer alone had no effect ( Fig. 1, A , B, E, and F). Microinjection of 0.1 or 1 nM NAADP ϩ was without effect in most of the cells (Fig. 1 , C and D, and data not shown). At a pipette concentration of 50 nM NAADP ϩ , an initial, rapidly occurring Ca 2ϩ -peak with a high amplitude was observed which turned into gradually lowering oscillations during the first 350-400 s. After this time period, the calcium response changed into a low, but sustained, plateau phase with very small oscillations (Fig. 1, G and H) . At pipette concentrations of 100 nM and 1 M, similar responses were observed ( Fig. 1, I -L). However, the peak amplitude of the initial Ca 2ϩ -spike declined with increasing NAADP ϩ concentrations (Fig. 1 , J and L), and the decay of the Ca 2ϩ -signal was accelerated ( Fig. 1 H, J, and L). At 10 M NAADP ϩ , the Ca 2ϩ -response appeared similar to the one at 1 nM (Fig. 1, M and N) , whereas at 100 M NAADP ϩ , no signal was detectable (Fig. 1, O and P) . The dose response relationship shows a bell-shaped curve for the initial Ca 2ϩ -peak with an optimal NAADP ϩ concentration at 100 nM ( Fig. 2 A) . However, only minor changes of the long-lasting Ca 2ϩ -signal as measured at 400 s were observed in response to 100 nM NAADP ϩ (Fig. 2 B) . These data indicate that, similar to the few other cellular systems investigated so far (Chini et al., 1995; Lee and Aarhus, 1995; Albrieux et al., 1998; Cancela et al., 1999) , NAADP ϩ at low nanomolar concentrations activates Ca 2ϩ -signaling in T cells, whereas micromolar concentrations of NAADP ϩ rapidly cause self inactivation of the Ca 2ϩ -release system. To prove the specificity of the effect of NAADP ϩ on intracellular Ca 2ϩ -signaling in T cells, NADP ϩ was used in parallel microinjection experiments. NADP ϩ is a structurally similar molecule, bearing a nicotinamide group instead of the nicotinic acid group. In contrast to NAADP ϩ , microinjection of NADP ϩ (50 nM) was completely without effect on Ca 2ϩ -signaling (Fig. 3, A and B) . The Ca 2ϩ -release system that is targeted by NAADP ϩ
has not yet been identified, but work in other cell systems indicates that neither the Ins(1,4,5)P 3 receptor (InsP3-R) nor the RyR are involved (Chini et al., 1995; Lee and Aarhus, 1995) . However, both of these classical intracellular Ca 2ϩ -release systems have been demonstrated to be essential parts of the Ca 2ϩ -signaling machinery of T cells (Jayaraman et al., 1995; Guse et al., 1999) . Thus, the next series of experiments was designed to investigate potential interrelations between the NAADP ϩ system on one hand and both the Ins(1,4,5)P 3 and cADPR systems on the other.
The specific cADPR antagonist 8-OCH 3 -cADPR (Guse et al., 1999) , when coinjected with an optimal NAADP ϩ concentration, did not significantly affect NAADP ϩ -mediated Ca 2ϩ -signaling (Fig. 4 , A and F vs. B and G). However, when a self-desensitizing concentration of NAADP ϩ (10 M) was coinjected with a stimulating concentration of cADPR (10 M), a massive decrease of the cADPRmediated Ca 2ϩ -signal was observed (Fig. 4 , C and H vs. E and J). On the other hand, an optimal stimulating concentration of NAADP ϩ (50 nM) microinjected together with cADPR (10 M) did not significantly change the Ca 2ϩ -signals (Fig. 4, D and I vs. E and J). These data indicate that a functional, nondesensitized NAADP ϩ /Ca 2ϩ -release system is necessary for cADPR-mediated Ca 2ϩ -release. The specific Ins(1,4,5)P 3 antagonist, Ins(1,4,6)PS 3 (Guse et al., 1997; Murphy et al., 2000) , was also coinjected with an optimal NAADP ϩ concentration. Surprisingly, there was a partial reduction of the initial Ca 2ϩ -peak, but also a faster decay of this peak as compared with injection of NAADP ϩ alone (Fig. 5, A and F vs. B and G) . Similar to the cADPR system, there was an almost complete inhibition of Ins(1,4,5)P 3 -mediated Ca 2ϩ -release when a desensitizing concentration of NAADP ϩ was coinjected (Fig. 5 , C and H). Coinjection of an optimal stimulating concentration of NAADP ϩ , together with Ins(1,4,5)P 3 , resulted in a high initial Ca 2ϩ -peak (Fig. 5 , D and I) that was comparable to the peak observed in response to injection of NAADP ϩ alone (Fig. 5 , B and C), whereas much less oscillatory activity of the cells after the initial peak was observed (Fig. 5, D and I) as compared with Ins(1,4,5)P 3 alone (Fig. 5, E and J) . These data also indicate that the Ins(1,4,5)P 3 /Ca 2ϩ -release system requires a functional nondesensitized NAADP ϩ /Ca 2ϩ -release system. Moreover, a part of the Ca 2ϩ -signal observed in response to microinjection of NAADP ϩ alone appears to be mediated by Ins(1,4,5)P 3 (Fig. 5, A, F, B, and G) . This may be explained by the coagonistic effect of Ca 2ϩ released by NAADP ϩ , which then acts together with basal Ins(1,4,5)P 3 at the InsP 3 -R; this coagonistic effect of Ca 2ϩ at the InsP 3 -R has been demonstrated previously (Bezprozvanny et al., 1991) .
Both the Ins(1,4,5)P 3 /Ca 2ϩ -and the cADPR/Ca 2ϩ - -signaling. Jurkat T-lymphocytes were loaded with Fura2/AM, and ratiometric Ca 2ϩ imaging and parallel microinjection in the presence of 1 mM extracellular Ca 2ϩ was carried out as detailed under Materials and Methods. Left, Overlays of single tracings of individual cells after injection (A-E); right, demonstrates the corresponding averages from these overlays (F-J). Shown are (n ϭ number of experiments): A/F, coinjection of NAADP (50 nM) and 8-OCH 3 -cADPR (100 M; n ϭ 7); B/G, injection of NAADP ϩ (50 nM, n ϭ 10); C/H, coinjection of NAADP ϩ (10 M) and cADPR (10M; n ϭ 7); D/I, coinjection of NAADP ϩ (50 nM) and cADPR (10 M; n ϭ 5); and E/J, injection of cADPR (10 M, n ϭ 5).
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ϩ : A Regulator for T Cell Ca 2ϩ -signaling 585 release systems have been published to be essential parts of the Ca 2ϩ -signaling machinery of T cells upon stimulation of the TCR/CD3 complex (Jayaraman et al., 1995; Guse et al., 1999 ). Since the data described above indicate that a functional NAADP ϩ /Ca 2ϩ -release system is essential for both Ins(1,4,5)P 3 -and cADPR-mediated Ca 2ϩ -release, we investigated the effect of NAADP ϩ on Ca 2ϩ -signaling mediated by anti-CD3 mAb OKT3 (Fig. 6) . Microinjection of 50 nM NAADP ϩ before stimulation of the cells by extracellular addition of OKT3 did not significantly change the OKT3-mediated Ca 2ϩ -signal (Fig. 6 , A and B). However, there was a dramatic inhibition of OKT3-mediated Ca 2ϩ -signaling when a desensitizing concentration of NAADP ϩ was microinjected before stimulation by OKT3 (Fig. 6 C) .
Discussion
The main findings of this report are: a dose-dependent and specific effect of NAADP ϩ in T cell Ca 2ϩ -signaling; the strict dependence of both Ins(1,4,5)P 3 -and cADPR-mediated Ca 2ϩ -release upon a functional NAADP ϩ /Ca 2ϩ -release system; and inhibition of Ca 2ϩ -signaling mediated by ligation of the TCR/CD3 complex by prior self inactivation of the NAADP ϩ /Ca 2ϩ -release system. In sea urchin eggs, Ca 2ϩ -release by NAADP ϩ was halfmaximal between 16 and 30 nM, and showed saturation between ‫001ف‬ and 400 nM (Chini et al., 1995; Lee and Aarhus, 1995) . In ascidian oocytes and mouse pancreatic acinar cells, effective concentrations between 10 and 50 nM were observed (Albrieux et al., 1998; Cancela et al., 1999) , although in brain microsomes 1 M NAADP ϩ was necessary (Bak et al., 1999) . These data fit very well to our current data in Jurkat T cells, the first human cell system where an effect of NAADP ϩ is reported. Ca 2ϩ -mobilizing concentrations were in the range between 10 and 100 nM ( Figs. 1 and 2 ), whereas at concentrations Ն1 M, partial or complete self inactivation was observed (Figs. 1 and 2) .
The self inactivation properties of the NAADP ϩ /Ca 2ϩ -release system, at least in sea urchin eggs, appear to be unique as compared with the known Ca 2ϩ -mobilizing second messengers, Ins(1,4,5)P 3 and cADPR (Aarhus et al., 1996; . Especially the fact that subthreshold concentrations of NAADP ϩ (2 to 4 nM) almost completely inhibited subsequent Ca 2ϩ -release by a high concentration of NAADP ϩ (Aarhus et al., 1996; indicates that activation of the NAADP ϩ / Ca 2ϩ -release system followed by its rapid inactivation can supply the cell with a short pulse of elevated Ca 2ϩ only, and that the basal endogenous concentration of NAADP ϩ must be below a concentration that would permanently inactivate the system, e.g., in sea urchin eggs below 0.1 nM ( Aarhus et al., 1996) or even less . Data in mammalian cell types, pancreatic acinar cells , and T cells, however, indicate that low concentrations of NAADP ϩ do not substantially selfinactivate the system, e.g., microinjections of 10 nM NAADP ϩ in the majority of cases stimulated long-lasting trains of low-amplitude Ca 2ϩ -spikes in T cells (Fig. 1 E) , and infusion of 50 nM NAADP ϩ into acinar cells evoked sustained Ca 2ϩ -spiking . To completely unravel the role of NAADP ϩ , mainly to verify (or to falsify) its status as a second messenger, measurement of the endogenous concentration of NAADP ϩ would be helpful. However, regarding the theoretically expected concentrations of Յ0.1 nM in unstimulated cells and 50-100 nM NAADP ϩ in stimulated cells, it might be very difficult to develop an analytical system to measure these low concentrations. Our recently developed HPLC systems for the mass determination of Ins(1,4,5)P 3 (Guse et al., 1995) and cADPR (da Silva et al., 1998) require 0.5-1 ϫ 10 8 cells per sample to measure these compounds in the low micromolar range. To measure basal NAADP ϩ concentrations a 1,000-fold more sensitive analytical method would be required. Potential methods to achieve this may include labeling of NAADP ϩ by a fluorescent dye (pre-or postcolumn derivatization) combined with a very sensitive fluorescence detector, e.g., laser-induced fluorescence detection (Rahavendran and Karnes, 1993) . Alternatively, a competitive protein binding assay based on a high affinity binding protein for NAADP ϩ may also be sufficient.
As discussed above, regarding the NAADP ϩ /Ca 2ϩ -release system, there are similarities between mouse pancreatic acinar cells and human T cells, e.g., a very similar dose-response relationship for NAADP ϩ , and the fact that self inactivation of the NAADP ϩ /Ca 2ϩ -release renders both cell types insensitive to physiological stimulation. However, there are also at least three clear differences between the two cell systems: inhibition of either the cADPR/Ca 2ϩ -release system or the Ins(1,4,5)P 3 /Ca 2ϩ -release system in pancreatic acinar cells completely blocked NAADP ϩ -mediated Ca 2ϩ -signaling , whereas similar inhibition protocols were without or almost without effect in T cells; self inactivation of the NAADP ϩ /Ca 2ϩ -release system did not influence Ca 2ϩ -signaling mediated by infusion of cADPR or Ins(1,4,5)P 3 in acinar cells , whereas in T cells such self-inactivation of the NAADP ϩ /Ca 2ϩ -release system almost completely inhibited subsequent signaling by cADPR or Ins(1,4,5)P 3 ; and in acinar cells, the sustained phase of Ca 2ϩ -spiking induced by infusion of cADPR could be blocked by the Ins(1,4,5)P 3 antagonist heparin (Thorn et al., 1994) , whereas in T cells there was no effect of the Ins(1,4,5)P 3 antagonist, Ins(1,4,6)PS 3 , on cADPRmediated Ca 2ϩ -signaling (Guse et al., 1997) . Using the data obtained from pancreatic acinar cells, Petersen and Cancela (1999) (Petersen and Cancela, 1999) . Only this last element is measurable as a Ca 2ϩ -spike, whereas the trigger and amplifier element, provided by NAADP ϩ and the Ca 2ϩ -induced Ca 2ϩ -release mechanism modulated by cADPR, appear to be too small to be detected by patch clamp measurements of the Ca 2ϩ -dependent currents (Petersen and Cancela, 1999) .
In contrast to acinar cells, in Jurkat T cells NAADP ϩ produced a substantial Ca 2ϩ -spike, even if cADPR-and Ins(1,4,5)P 3 -antagonists were present (Figs. 4, A and F, and 5, A and F) . The second main difference to acinar cells was that in Jurkat T cells, Ca 2ϩ -signaling by cADPR and Ins(1,4,5)P 3 depended on a functional NAADP ϩ /Ca 2ϩ -release system (Figs. 4, C and H, and 5, C and H) . Although two different methods were used to detect the Ca 2ϩ -spikes: patch clamp measurements of the Ca 2ϩ -dependent currents vs. single cell Ca 2ϩ imaging using Fura2-loaded cells, this is unlikely to be the reason for the differences observed. Thus, the model developed for the acinar cells (Petersen and Cancela, 1999) needs some modification to fit to the data obtained in Jurkat T cells. In accordance with the acinar cell model, NAADP ϩ appears to act first in sequence providing trigger-calcium needed for the two other Ca 2ϩ -release systems. Because of the experimental difficulties to measure nanomolar concentrations of NAADP ϩ in cells as discussed above, it is unclear whether 
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NAADP ϩ concentrations in fact do increase upon stimulation, or whether NAADP ϩ stays unaltered in the low nanomolar range keeping the T cell in an excitable state. Experimental evidence for the latter may be obtained by high temporal and spatial resolution Ca 2ϩ imaging experiments in Jurkat T cells; preliminary data indicate a basal Ca 2ϩ -signaling activity of very low amplitude in nonstimulated cells (Guse, A.H., and S. Heidbrink, unpublished results) . However, trigger-calcium provided by NAADP ϩ further acts in concert with Ins(1,4,5)P 3 , which is rapidly, but transiently, formed in the first minutes of T cell activation (Brattsand et al., 1990; Ng et al., 1990) , and then with cADPR, which is elevated during the sustained phase of T cell Ca 2ϩ -signaling (Guse et al., 1999) . However, despite these differences between acinar and T cells the dependence of cholecystokinin receptor-mediated Ca 2ϩ -signaling on a Ca 2ϩ -trigger supplied by an initial NAADP ϩ -mediated Ca 2ϩ -release event to integrate the Ca 2ϩ -amplifier, cADPR, and the Ca 2ϩ -oscillator, Ins(1,4,5)P 3 (Petersen and Cancela, 1999) , exactly mirrors the situation observed in Jurkat T cells. As shown in Fig. 6 , if the NAADP ϩ /Ca 2ϩ -release system was inactivated by high NAADP ϩ concentrations subsequent quasiphysiological stimulation of the T cell by anti-CD3 mAb did not result in any Ca 2ϩ -signaling. This result is in complete accordance with the inhibition of cADPR-or Ins(1,4,5)P 3 -mediated Ca 2ϩ -signaling by coinjection of NAADP ϩ (Figs. 4, C and H, and 5, C and H) since Ca 2ϩ -signaling in T cells critically depends on these two second messengers (Jayaraman et al., 1995; Guse et al., 1999) .
More generalized, if the NAADP ϩ /Ca 2ϩ -release system acts as the Ca 2ϩ -providing trigger, the complex behavior of activation and inactivation opens a multitude of regulatory possibilities: simply by changing their endogenous NAADP ϩ concentration cells might regulate the status of the NAADP ϩ /Ca 2ϩ -release system; e.g., by increasing NAADP ϩ the NAADP ϩ /Ca 2ϩ -release system will become inactivated, and Ca 2ϩ -signaling will in turn be completely unresponsive. For T-lymphocytes, such behavior of unresponsiveness to antigenic or mitogenic stimulation is well known as anergy (Jenkins et al., 1987) ; however, it is less clear which intracellular mechanism is responsibly involved. Our data indicate that the NAADP ϩ /Ca 2ϩ -release system with its complex inactivation/activation properties might be such a mechanism underlying anergy in T cells.
From an evolutionary point of view, it is of particular interest that both a very similar dose-response relationship and the self inactivation property of the NAADP ϩ /Ca 2ϩ -release have been conserved between sea urchin eggs, ascidian oocytes, and higher eukaryotic cells from pancreas and lymphocytes. This indicates that these two characteristic features are of outstanding importance for the regulation of intracellular Ca 2ϩ -signaling in general. One of the important future aspects will be the identification of the molecular target for NAADP ϩ . In addition to the model for pancreatic acinar cells Petersen and Cancela, 1999) in which a separate NAADP ϩ receptor has been suggested, it might also be possible that NAADP ϩ acts as a comessenger at the known intracellular Ca 2ϩ -release channels, the Ins(1,4,5)P 3 receptor and/or the RyR. Along these lines, the fluorescent 1,N 6 -etheno-NAADP ϩ has been shown to release Ca 2ϩ in sea urchin eggs (Lee and Arhus, 1998) , and thus, may serve as a tool to identify the receptor for NAADP ϩ .
